Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages

dc.contributor.authorAu-Yeung, KKW
dc.contributor.authorYip, JCW
dc.contributor.authorSiow, YL
dc.contributor.authorO, K
dc.date.accessioned2007-10-09T19:00:18Z
dc.date.available2007-10-09T19:00:18Z
dc.date.issued2006-01-31
dc.description.abstractFolic acid supplementation is a promising approach for patients with cardiovascular diseases associated with hyperhomocysteinerma. We have demonstrated that homocysteine (Hey) activates nuclear factor-kappa B (NF-kappa B), a transcription factor that plays an important role in inflammatory responses. The aim of the present Study was to investigate the effect of folic acid on Hcy-induced NF-kappa B activation in macrophages. Hey treatment (100 mu mol/L) resulted in NF-kappa B activation and increased monocyte chemoattractant protein-1 (MCP-1) expression in THP-1 derived macrophages. Hcy-induced NF-kappa B activation was associated with a significant increase in the intracellular Superoxide anion levels. There was a significant increase in phosphorylation and membrane translocation of NADPH oxidase p47(phox) subunit in Hcy-treated cells. Addition of folic acid (200 ng/mL) to the culture medium abolished NADPH oxidase-dependent Superoxide anion generation in macrophages by preventing phosphorylation of: p47(phox) subunit. Consequently, Hcy-induced NF-kappa B activation and MCP-1 expression was inhibited. Such an inhibitory effect of folic acid was independent of its Hcy-lowering ability. Taken together, these results suggest that folic acid treatment can effectively inhibit Hcy-induced oxidative stress and inflammatory responses in macrophages. This may represent one of the mechanisms by which folic acid supplementation exerts a protective effect in cardiovascular disorders.en
dc.format.extent271896 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.citation0008-4212; CAN J PHYSIOL PHARMACOL, JAN 2006, vol. 84, no. 1, p.141 to 147.en
dc.identifier.doihttp://dx.doi.org/10.1139/Y05-136
dc.identifier.urihttp://hdl.handle.net/1993/2918
dc.language.isoengen_US
dc.rightsNo part of the NRC Research Press electronic journals may be reproduced, stored, or transmitted in any form or by any means, without the written permission of the publisher, except as stated below. Under the Canadian Copyright Act, individuals may download or print single copies of articles for personal research or study. Any person may reproduce short excerpts from articles in the journals for any purpose that respects the moral rights of authors, provided that the source is fully acknowledged. As a courtesy, the consent of authors of such material should be obtained directly from the author. Authorization to reproduce items for other than personal research or study, as stated above, may be obtained via Access © upon payment of the copyright fee of $10.00 per copy. NRC Research Press also extends certain additional rights to authors. The above rights do not extend to copying or reproduction for general distribution, for advertising or promotional purposes, for creating new collective works, or for resale. For such copying or reproduction, arrangements must be made with NRC Research Press.en
dc.rightsopen accessen_US
dc.statusPeer revieweden
dc.subjecthomocysteineen
dc.subjectfolic aciden
dc.subjectoxidative stressen
dc.subjectNADPH oxidaseen
dc.subjectNF-kappa Ben
dc.subjectCHEMOATTRACTANT PROTEIN-1 EXPRESSIONen
dc.subjectCORONARY-ARTERY DISEASEen
dc.subjectENDOTHELIAL DYSFUNCTIONen
dc.subjectNADPH-OXIDASEen
dc.subjectSMOOTH-MUSCLEen
dc.subjectPLASMA HOMOCYSTEINEen
dc.subjectOXIDATIVE STRESSen
dc.subjectVASCULAR-DISEASEen
dc.subjectHYPERHOMOCYSTEINEMIAen
dc.titleFolic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophagesen
dc.typejournal articleen_US
Files